Clinical application of next-generation sequencing for the diagnosis of lung squamous cell carcinoma: Is it primary or secondary?

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

An 80-year-old man with a history of cutaneous squamous cell carcinoma (SCC) was referred to our department for a solitary lung nodule. The nodule was surgically resected and diagnosed as SCC. Because the lung lesion and a previous skin lesion showed similar histological findings, the origin of the lung tumor was uncertain. Next-generation sequencing using a targeted driver oncogene panel was applied for the further examination. The lung lesion was diagnosed as primary lung SCC, as the two tumors possessed distinct somatic mutations in TP53. Recent advances in clinical sequencing have enabled us to obtain an accurate diagnosis in pathologically challenging cases.

Cite

CITATION STYLE

APA

Aizawa, H., Karasaki, T., Nagayama, K., Shinozaki-Ushiku, A., Aburatani, H., Mano, H., & Nakajima, J. (2020). Clinical application of next-generation sequencing for the diagnosis of lung squamous cell carcinoma: Is it primary or secondary? Internal Medicine, 59(10), 1299–1302. https://doi.org/10.2169/internalmedicine.3682-19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free